We are live on ! Find out more
INVA icon

Innoviva

149 hedge funds and large institutions have $4.11B invested in Innoviva in 2013 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 63 increasing their positions, 43 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

47% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 43

35% more call options, than puts

Call options by funds: $35.8M | Put options by funds: $26.6M

23% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 26

4% more funds holding

Funds holding: 143149 (+6)

0% less capital invested

Capital invested by funds: $4.12B → $4.11B (-$11.2M)

17% less funds holding in top 10

Funds holding in top 10: 65 (-1)

Holders
149
Holders Change
+6
Holders Change %
+4.2%
% of All Funds
4.33%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.15%
New
32
Increased
63
Reduced
43
Closed
26
Calls
$35.8M
Puts
$26.6M
Net Calls
+$9.19M
Net Calls Change
-$7.6M
Name Holding Trade Value Shares
Change
Change in
Stake
Deutsche Bank
26
Deutsche Bank
Germany
$18.6M +$2.46M +84,118 +15%
Renaissance Technologies
27
Renaissance Technologies
New York
$17.6M +$1.26M +43,063 +8%
AQR Capital Management
28
AQR Capital Management
Connecticut
$16.1M +$16.4M +561,718 New
T. Rowe Price Associates
29
T. Rowe Price Associates
Maryland
$15.9M -$57.1M -1,951,484 -78%
SONJCPFA
30
State of New Jersey Common Pension Fund A
New Jersey
$15.7M
Geode Capital Management
31
Geode Capital Management
Massachusetts
$13.6M +$2.49M +85,124 +22%
Northern Trust
32
Northern Trust
Illinois
$12.2M +$1.08M +37,003 +10%
Millennium Management
33
Millennium Management
New York
$12.1M +$1M +34,295 +9%
State of Wisconsin Investment Board
34
State of Wisconsin Investment Board
Wisconsin
$11.6M +$28.5K +973 +0.2%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$11.5M -$1.83M -62,597 -14%
ARC
36
Absolute Return Capital
Massachusetts
$11.4M +$989K +33,816 +9%
TA
37
Teachers Advisors
New York
$10.7M +$306K +10,464 +3%
Nomura Holdings
38
Nomura Holdings
Japan
$9.77M -$1.64M -56,149 -14%
CS
39
Credit Suisse
Switzerland
$9.54M -$599K -20,472 -6%
D.E. Shaw & Co
40
D.E. Shaw & Co
New York
$9.01M +$1.67M +57,190 +22%
RP
41
Realm Partners
New York
$8.59M +$3.04M +104,012 +53%
Lazard Asset Management
42
Lazard Asset Management
New York
$8.33M
FAM
43
Foundation Asset Management
New York
$7.91M +$8.05M +275,249 New
PAM
44
Panagora Asset Management
Massachusetts
$7.49M -$1.06M -36,391 -12%
PWAM
45
Park West Asset Management
California
$6.37M +$6.49M +221,767 New
GC
46
Guggenheim Capital
Illinois
$6.37M -$130K -4,444 -2%
Axa
47
Axa
France
$6.35M +$322K +10,999 +5%
State Board of Administration of Florida Retirement System
48
State Board of Administration of Florida Retirement System
Florida
$5.34M -$11K -377 -0.2%
AllianceBernstein
49
AllianceBernstein
Tennessee
$5.29M +$629K +21,488 +13%
VOYA Investment Management
50
VOYA Investment Management
Georgia
$5.27M +$1.49M +51,005 +39%

INVA Hedge Fund Activity: Q4 2013 in Review

149 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Innoviva (INVA) for Q4 2013, worth a combined $4.11B — down 0.27% from $4.12B a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new INVA positions and 26 closed out — a net gain of 6 holders — while 63 added to existing stakes and 43 trimmed.

The largest buyer was Baupost Group, adding an estimated $59.3M. The largest seller was BNP Paribas Financial Markets, exiting entirely with an estimated $182M sold.

  • 149 institutional investors held Innoviva (INVA) as of Q4 2013, up from 143 in Q3 2013.
  • Funds reported $4.11B of Innoviva stock for Q4 2013, down 0.27% quarter-over-quarter.
  • 32 funds opened new Innoviva positions in Q4 2013 and 26 closed out, a net change of +6 holders.
  • The largest Innoviva buyer in Q4 2013 was Baupost Group, an estimated $59.3M added.
  • The largest Innoviva seller in Q4 2013 was BNP Paribas Financial Markets, an estimated $182M sold.

Based on aggregated 13F filings for Q4 2013.